{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:25:46Z","timestamp":1792095946326,"version":"4.4.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.radonc.2011.05.067","type":"journal-article","created":{"date-parts":[[2011,6,22]],"date-time":"2011-06-22T20:50:38Z","timestamp":1308775838000},"page":"177-182","source":"Crossref","is-referenced-by-count":50,"title":["Radioresistant head and neck squamous cell carcinoma cells: Intracellular signaling, putative biomarkers for tumor recurrences and possible therapeutic targets"],"prefix":"10.1016","volume":"101","author":[{"given":"Sergej","family":"Skvortsov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie R.","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaco C.","family":"Knol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Eichberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Schiestl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Debbage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Skvortsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2011.05.067_b0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00066-010-2139-9","article-title":"Outcome after re-irradiation of head and neck cancer patients","volume":"187","author":"Platteaux","year":"2011","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2011.05.067_b0010","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ijrobp.2008.05.042","article-title":"Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinoma","volume":"73","author":"Nuyts","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2011.05.067_b0015","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1056\/NEJM199301213280306","article-title":"Head and neck cancer","volume":"328","author":"Vokes","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2011.05.067_b0020","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.radonc.2009.08.038","article-title":"Incidence of isolated regional recurrence after definitive (chemo-) radiotherapy for head and neck squamous cell carcinoma","volume":"93","author":"Lambrecht","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2011.05.067_b0025","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/cncr.24123","article-title":"Targeted therapies in squamous cell carcinoma of the head and neck","volume":"115","author":"Gold","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2011.05.067_b0030","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/cncr.20640","article-title":"Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck","volume":"101","author":"Argiris","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2011.05.067_b0035","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.radonc.2009.10.012","article-title":"Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory","volume":"93","author":"Duprez","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2011.05.067_b0040","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.radonc.2007.04.002","article-title":"Evidence-based radiation oncology in head and neck squamous cell carcinoma","volume":"85","author":"Corvo","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2011.05.067_b0045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.radonc.2010.10.025","article-title":"Hypofractionated accelerated CT-guided interstitial (1)(2)Ir-HDR-Brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer","volume":"98","author":"Tselis","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2011.05.067_b0050","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2010.06.005","article-title":"Down-regulation of survivin by oxaliplatin diminishes radioresistance of head and neck squamous carcinoma cells","volume":"96","author":"Khan","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2011.05.067_b0055","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.jprot.2010.01.013","article-title":"Protein biomarker discovery for head and neck cancer","volume":"73","author":"Schaaij-Visser","year":"2010","journal-title":"J Proteomics"},{"key":"10.1016\/j.radonc.2011.05.067_b0060","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.clon.2005.02.014","article-title":"A retrospective analysis of the outcome of patients with recurrent and\/or metastatic squamous cell carcinoma of the head and neck refractory to a platinum-based chemotherapy","volume":"17","author":"Leon","year":"2005","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2011.05.067_b0065","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1002\/pmic.200800113","article-title":"Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells","volume":"8","author":"Skvortsova","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.radonc.2011.05.067_b0070","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1158\/1535-7163.MCT-06-0708","article-title":"Antitumor activity of CTFB, a novel anticancer agent, is associated with the down-regulation of nuclear factor-{kappa}B expression and proteasome activation in head and neck squamous carcinoma cell lines","volume":"6","author":"Skvortsov","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.radonc.2011.05.067_b0075","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1269\/jrr.47.183","article-title":"Rituximab enhances radiation-triggered apoptosis in non-Hodgkin\u2019s lymphoma cells via caspase-dependent and \u2013 independent mechanisms","volume":"47","author":"Skvortsova","year":"2006","journal-title":"J Radiat Res (Tokyo)"},{"key":"10.1016\/j.radonc.2011.05.067_b0080","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.radonc.2010.04.017","article-title":"Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement of squamous cell carcinoma radioresponse","volume":"96","author":"Skvortsova","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2011.05.067_b0085","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.radonc.2011.03.004","article-title":"Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck \u2013 a systematic review and meta-analysis","volume":"100","author":"Overgaard","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2011.05.067_b0090","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.radonc.2010.10.015","article-title":"Patterns of relapse following definitive treatment of head and neck squamous cell cancer by intensity modulated radiotherapy and weekly cisplatin","volume":"98","author":"Loimu","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2011.05.067_b0095","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.radonc.2009.05.019","article-title":"Proteins upregulated by mild and severe hypoxia in squamous cell carcinomas in vitro identified by proteomics","volume":"92","author":"Sorensen","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2011.05.067_b0100","first-page":"1166","article-title":"Moesin-dependent cytoskeleton remodelling is associated with an anaplastic phenotype of pancreatic cancer","volume":"14","author":"Abiatari","year":"2010","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.radonc.2011.05.067_b0105","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1755-148X.2009.00650.x","article-title":"Moesin\/ezrin: a specific role in cell metastasis?","volume":"23","author":"Lallemand","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.radonc.2011.05.067_b0110","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1242\/jcs.053157","article-title":"Moesin orchestrates cortical polarity of melanoma tumour cells to initiate 3D invasion","volume":"122","author":"Estecha","year":"2009","journal-title":"J Cell Sci"},{"key":"10.1016\/j.radonc.2011.05.067_b0115","doi-asserted-by":"crossref","first-page":"10600","DOI":"10.1158\/0008-5472.CAN-07-0055","article-title":"Interaction of the tumor metastasis suppressor nonmetastatic protein 23 homologue H1 and estrogen receptor alpha alters estrogen-responsive gene expression","volume":"67","author":"Curtis","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2011.05.067_b0120","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/01.ju.0000051580.89109.4b","article-title":"Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site","volume":"169","author":"Kauffman","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.radonc.2011.05.067_b0125","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11010-008-9955-6","article-title":"Inhibition of migration and invasion of colorectal cancer cells via deletion of Rac1 with RNA interference","volume":"322","author":"Zhao","year":"2009","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.radonc.2011.05.067_b0130","first-page":"348","article-title":"Novel inhibitors of Rac1 in metastatic breast cancer","volume":"29","author":"Hernandez","year":"2010","journal-title":"PR Health Sci J"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814011002763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814011002763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T22:53:04Z","timestamp":1543704784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814011002763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0167814011002763"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2011.05.067","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}